News

As patients faced both high rates of inflation and record high costs at the pharmacy counter, President Biden signed the Inflation...

Legislation will rein in the profiteering, anticompetitive and anti-consumer practices of PBMs, creating price transparency, making...

In an interview with Pharmacy Times, Cheryl Larson, president and CEO of the Midwest Business Group on Health, discussed the employers’...

A federal court decision that struck down expanded use of copay accumulator programs should prompt health insurers and pharmacy benefit...

The current drug pricing market is malfunctioning, an obvious conclusion to anyone who is paying attention. But why? Like much of the...

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the...

As we approach the end of the year, businesses are facing a 10-year high health care cost hike. While ballooning prices affect all...

U.S. Representatives Mariannette Miller-Meeks (IA-01), Nanette Diaz Barragán (CA-44), Lori Chavez-DeRemer (OR-05), Kathy Manning (NC-06),...

In a unanimous 26-0 vote, the Senate Finance Committee passed a comprehensive draft package this week that puts pharmacy benefit manager...

The Senate Finance Committee today unanimously advanced a broad legislative package addressing mental health, PBMs and Medicare payment...

In recent years, the practices of pharmacy benefit managers (PBMs), initially formed to foster competition in the pharmaceutical market...

Most Americans believe drugs cost too much and big pharma is to blame. That powerful political sentiment undergirds Medicare’s new...

A government shutdown has been averted—for now. Congress approved a continuing resolution this weekend that funds the government through...

Prior to the COVID-19 pandemic, few healthcare issues received as much attention and public discourse as prescription drug prices. The...

Momentum Building for Legislation that Separates PBM Income from the Price of Prescription Medicines Washington, DC – The PBM...

Representatives Mariannette Miller-Meeks (IA-01), Deborah Ross (NC-02), Earl L. “Buddy” Carter (GA-01) and Scott Peters (CA-50) have...

The cancer drug Gleevec went generic in 2016 and can be bought today for as little as $55 a month. But many patients’ insurance plans are...

U.S. Representatives Mariannette Miller-Meeks (IA-01), Deborah Ross (NC-02), Earl L. “Buddy” Carter (GA-01) and Scott Peters (CA-50)...

The pharmaceutical market has experienced a massive wave of vertical integration between pharmacy benefit managers (PBMs) and health...

The Senate Finance Committee recently passed a pharmacy benefit managers (PBM) reform package, one of the most significant steps towards...

The supply chain that brings pharmaceutical drugs from the factory to the pharmacy is long, complex and unclear. Congress and several...

In a largely harmonious Senate Committee on Finance markup hearing, members supported bipartisan efforts to rein in pharmacy benefit...

The pressure continues to build against pharmacy benefit managers and their practices that critics say raise drug prices. This time, it’s...